NDC 52261-1130-01 - Maxxed Clinical Grade Facial Wipes with 2% Salicylic Acid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52261-1130
- Requested NDC
- 52261-1130-01
- Package NDCs from labels
- 52261-1130-1, 52261-1130-01
- Manufacturer
- Cosco International, Inc.
- Effective date
- 2026-10-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Maxxed Clinical Grade Facial Wipes with 2% Salicylic Acid | Cosco International, Inc. | 2026-10-12 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Salicylic Acid | MEDICATED CORN REMOVERS | LEADER/ Cardinal Health 110, Inc. | 93671987-00f2-4f81-ab84-c53e163d120b | 2026-10-08 | Warnings | O414PZ4LPZ |
| Salicylic Acid | LIQUID CORN AND CALLUS REMOVER | LEADER/ Cardinal Health 110, Inc. | 61edf291-cf65-4b57-b9b0-c6204c446f0b | 2026-10-08 | Warnings | O414PZ4LPZ |
| Salicylic Acid | LIQUID WART REMOVER | LEADER/ Cardinal Health 110, Inc. | dd63808a-cae4-4068-a228-f43b3012cf52 | 2026-10-08 | Warnings | O414PZ4LPZ |
| Acne Spot Treatment Cream | BENZOYL PEROXIDE | CVS Health | 633fc7e1-5f71-4f9c-8d29-e3f2c4a5755b | 2026-10-08 | Warnings | M006 |
| Ultra Clear Foaming Cleanser | SALICYLIC ACID | Ultraceuticals Pty Ltd | 98d0def0-393d-1ebb-e053-2995a90a2513 | 2026-10-07 | Warnings | M006 O414PZ4LPZ |
| Ultra Clear Treatment | SALICYLIC ACID | Ultraceuticals Pty Ltd | 99b18387-4ab9-4975-e053-2995a90ad6c4 | 2026-10-07 | Warnings | M006 O414PZ4LPZ |
| VitaPhyte Lubricant Eye Drops | LUBRICANT EYE DROPS | Guangzhou Liyan Cosmetics Technology Co., Ltd. | 5d39f7b1-c0ed-33dc-e063-6394a90aee31 | 2026-10-07 | Warnings | PDC6A3C0OX |
| Clopoat CLOPOAT ACNE-CLEARING SPOT | COLLOIDAL SULFUR | Guangzhou Meixi Biotechnology Co., Ltd. | 5d287302-f72e-cf59-e063-6294a90aaad8 | 2026-10-06 | Warnings | M006 |
| Keralyt | SALICYLIC ACID | Summers Laboratories Inc | 8195e4e0-b812-11de-81b4-0002a5d5c51b | 2026-10-06 | Warnings, Adverse reactions | O414PZ4LPZ |
| LIQUIMAT ACNE TREATMENT AND COVER-UP | SULFUR | Summers Laboratories Inc | 3cb843ad-f52a-4876-b844-d441af08b27f | 2026-10-06 | Warnings | M006 |
| Acne Gel Pen | SALICYLIC ACID | Tiege Hanley | 4176d9b1-ca93-a6c4-e063-6394a90a68fb | 2026-10-06 | Warnings | M006 O414PZ4LPZ |
| Tiege Hanley | SALICYLIC ACID | Tiege Hanley | 1c1414ad-ba5f-51cc-e063-6294a90a66fb | 2026-10-06 | Warnings | M006 O414PZ4LPZ |
| Tiege Hanley Acne All Over Body | SALICYLIC ACID | Tiege Hanley | 46a4f734-1f73-1142-e063-6294a90a494a | 2026-10-06 | Warnings | M006 O414PZ4LPZ |
| Malin and Goetz Acne Treatment | SULFUR | Malin and Goetz Inc | 47390813-6bc9-44f4-b72a-d399d2c0de27 | 2026-10-06 | Warnings | M006 |
| SOLUMIRA WART REMOVER Cream | SALICYLIC ACID 17% WART REMOVER CREAM | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 5d374c1e-0a16-df23-e063-6294a90ad9df | 2026-10-06 | Warnings | O414PZ4LPZ |
| Uribel Tabs | METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFATE | Cintex Services, LLC | 5ccadff1-461a-335a-e063-6394a90ad5d7 | 2026-10-05 | Warnings, Adverse reactions | 8SKN0B0MIM |
| Clear Proof Acne Treatment Acne Medication | BENZOYL PEROXIDE | Mary Kay Inc. | e01859b1-057e-4b01-8b37-2df378aae212 | 2026-10-05 | Warnings | M006 |
| Clear Proof Acne System | SALICYLIC ACID | Mary Kay Inc. | 5d2e2315-e87e-758e-e063-6294a90ab558 | 2026-10-05 | Warnings | M006 |
| meijer Maximum Strength Sore Throat Fast Relief | PHENOL AND GLYCERIN | MEIJER DISTRIBUTION INC | f1f17aab-7ea7-4dac-a854-48b4b560ec4f | 2026-10-05 | Warnings | PDC6A3C0OX |
| Jonhoy WART REMOVER | SALICYLIC ACID 40% | Guangzhou Huixue Biotechnology Co., Ltd. | 5cff8436-3ee0-c084-e063-6394a90abc3a | 2026-10-04 | Warnings | O414PZ4LPZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.